Page last updated: 2024-09-05

nk3201 and angiotensin i

nk3201 has been researched along with angiotensin i in 1 studies

Compound Research Comparison

Studies (nk3201)	Trials (nk3201)	Recent Studies (post-2010) (nk3201)	Studies (angiotensin i)	Trials (angiotensin i)	Recent Studies (post-2010) (angiotensin i)
18	0	1	4,218	125	1,253

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ishida, K; Jin, D; Kamoshita, K; Miyazaki, M; Nishimoto, M; Sakaguchi, M; Sasaki, S; Sukenaga, Y; Takai, S; Yuda, A	1

Other Studies

1 other study(ies) available for nk3201 and angiotensin i

Article	Year
Oral administration of a specific chymase inhibitor, NK3201, inhibits vascular proliferation in grafted vein. Life sciences, 2001, Aug-31, Volume: 69, Issue:15 Topics: Acetamides; Administration, Oral; Angiotensin I; Animals; Carotid Arteries; Cell Division; Chymases; Culture Techniques; Dogs; Drug Antagonism; Graft Occlusion, Vascular; Muscle Contraction; Peptidyl-Dipeptidase A; Pyrimidines; Serine Endopeptidases; Serine Proteinase Inhibitors; Species Specificity; Veins	2001

Article

Year

Oral administration of a specific chymase inhibitor, NK3201, inhibits vascular proliferation in grafted vein.

Life sciences, 2001, Aug-31, Volume: 69, Issue:15

Topics: Acetamides; Administration, Oral; Angiotensin I; Animals; Carotid Arteries; Cell Division; Chymases; Culture Techniques; Dogs; Drug Antagonism; Graft Occlusion, Vascular; Muscle Contraction; Peptidyl-Dipeptidase A; Pyrimidines; Serine Endopeptidases; Serine Proteinase Inhibitors; Species Specificity; Veins

2001